Company Overview and News

 
Directors take advantage of share price increases on Hong Kong stock exchange to reduce stakes

2018-03-18 scmp
Selling among directors rose for the second straight week to HK$60 million in 34 firms compared with HK$57.5 million in 29 firms the previous week

 
Luxury set to come to Hong Kong Island’s old industrial south side as developers pay big for land

2017-12-05 scmp
Flats to be built on land at Wong Chuk Hang are likely to fetch prices similar to those in the city’s more traditional upmarket areas, analysts forecast

 
Shenzhen Investment and Road King wins Tuen Mun site for higher than expected HK$3.17 billion

2017-06-21 scmp
Shenzhen Investment, working in partnership with sister company Road King Infrastructure, beat out nine rival bidders for the Tuen Mun site, paying HK$3.17 billion

 
C-Suite Q&A: Road King diversifies to Hong Kong property

2017-06-06 scmp
Road King Infrastructure, which listed on the Hong Kong stock exchange in 1996, had operated as a toll road builder until 2004, when it set its eye on the fast growing property development in China.

 
Ping An Insurance raises 2016 dividend payment by 41.5pc on confident outlook

2017-03-23 scmp
Ping An Insurance, China’s largest insurer in terms of market value, said it will maintain a consistent dividend payout policy after it announced a 41.5 per cent increase in dividend payment for 2016.

 
Hong Kong’s biggest landowners usurped by mainland developers

2017-02-28 scmp
In the latest sign, Ping An Real Estate Capital’s venture with Road King Infrastructure outbid 13 developers to secure the right to develop a residential plot at Wong Chu Hang.

 
For Whom the Road Tolls: Reviewing Listed Toll Roads, Bridges and Tunnels

2016-09-17 seekingalpha
Toll roads are among the oldest businesses in the world. The idea of collecting a fee for the right of passage is several thousand years old. Nearly three thousand years ago, travelers had to pay a toll for using the Susa–Babylon highway under the regime of Ashurbanipal, who reigned in the seventh century BC. The business of toll collection has survived through the ages.

 
No August Doldrums in Emerging Markets as Bond Sales Jump: Chart - Bloomberg

2016-09-06 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
More Chinese property developers eye Hong Kong sites

2016-04-19 scmp
More and more mainland Chinese developers are setting their sights on Hong Kong’s land market to diversify in the wake of the a property market slowdown at home, especially in smaller cities, as well as to take advantage of the falling land prices in the city.

Related Articles

SGMO: Sangamo BioSciences and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

BSTG: Biostage Analysis and Research Report

2018-05-17 - Asif

Overview Biostage is a biotechnology company developing bioengineered organ implants based on its novel CellframeTM technology. The company's Cellframe technology is comprised of a biocompatible scaffold that is seeded with the recipient’s own stem cells. This technology is being developed to treat life-threatening conditions of the esophagus, trachea or bronchus with the objective of dramatically improving the treatment paradigm for those patients. The company believe that its Cellframe technology will provide surgeons with new ways to address damage to the esophagus, bronchus, and trachea due to congenital abnormalities, cancer, infection or trauma. Products being developed based on its Cellframe technology for those indications are called CellspanTM products. The company announced favorable preliminary pre-clinical results of large-animal studies for the esophagus, trachea and bronchus in November 2015. Since then, the Cellspan esophageal implant product candidates hav...